{"hands_on_practices": [{"introduction": "One of the most powerful lines of evidence in variant classification comes from large-scale population databases. The fundamental principle is that a truly pathogenic variant for a rare disease cannot be common in the general population. This practice [@problem_id:5021397] walks you through the quantitative reasoning behind this principle, challenging you to derive and calculate the maximum credible allele frequency ($AF_{\\text{max}}$) for a variant in an autosomal dominant disorder. Mastering this calculation is essential for correctly applying the ACMG/AMP Benign Strong (BS1) criterion.", "problem": "A laboratory is evaluating whether a missense variant in an autosomal dominant gene meets the Benign Strong 1 (BS1) criterion in the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) framework, which is applied when a population allele frequency is greater than that expected for a disorder. Use the following well-established definitions as your starting point: disease prevalence $K$ is the proportion of affected individuals in the population; genetic heterogeneity $g$ is the proportion of all cases attributable to the gene of interest; allelic heterogeneity $a$ is the maximum proportion of cases in that gene attributable to the specific variant under consideration; penetrance $\\pi$ is the probability that a carrier of the variant manifests the disease. Assume a rare autosomal dominant disease where homozygotes are negligible and most carriers are heterozygous, so population allele frequency approximates one-half of the carrier frequency.\n\nGiven $K = \\frac{1}{5000}$, $g = 0.2$, $a = 0.1$, and $\\pi = 0.5$, first derive from these definitions a formula for the maximum credible population allele frequency $AF_{\\max}$ for a potentially pathogenic variant in this dominant condition. Then compute $AF_{\\max}$ for the provided parameters. The observed gnomAD allele frequency is $AF_{\\text{obs}} = 0.0006$. Define the ratio $R = \\frac{AF_{\\text{obs}}}{AF_{\\max}}$. A value $R \\ge 1$ indicates that BS1 is supported for this dominant condition because the observed allele frequency is greater than the maximum credible frequency.\n\nReport the single numerical value of $R$ as your final answer. Round your final answer to three significant figures and express it as a unitless number.", "solution": "The problem statement is evaluated as valid. It is scientifically grounded in the principles of population genetics and the widely accepted ACMG/AMP framework for clinical variant classification. The problem is well-posed, providing all necessary definitions and data ($K, g, a, \\pi, AF_{\\text{obs}}$) to derive the formula and calculate the required ratio $R$. The terminology is precise and objective, and the assumptions (e.g., rare autosomal dominant disease where allele frequency is half the carrier frequency) are standard for this type of calculation. The problem does not violate any of the criteria for invalidity.\n\nThe primary task is to derive a formula for the maximum credible population allele frequency, $AF_{\\max}$, for a pathogenic variant, and then use it to compute the ratio $R$.\n\nThe derivation begins with the definitions provided:\n- $K$: The prevalence of the disease in the population.\n- $g$: The genetic heterogeneity, representing the proportion of disease cases attributable to the gene in question.\n- $a$: The allelic heterogeneity, representing the maximum proportion of cases within that gene attributable to the specific variant being assessed.\n- $\\pi$: The penetrance, which is the probability that a carrier of the variant will manifest the disease.\n\nFirst, we determine the maximum prevalence of the disease that can be attributed to the specific variant. This is found by multiplying the overall disease prevalence by the proportions for genetic and allelic heterogeneity. Let this variant-specific prevalence be $K_{\\text{variant}}$.\n$$K_{\\text{variant}} = K \\times g \\times a$$\n\nNext, we relate this prevalence to the frequency of individuals carrying the variant in the population. Let $CF$ be the carrier frequency of the variant. The number of affected individuals in the population due to this variant is the number of carriers multiplied by the probability that a carrier becomes affected (penetrance, $\\pi$). Therefore, the prevalence of the disease due to the variant can also be expressed as:\n$$K_{\\text{variant}} = CF \\times \\pi$$\n\nBy equating the two expressions for $K_{\\text{variant}}$, we can establish a relationship between the population genetics parameters and the carrier frequency. The maximum credible carrier frequency, $CF_{\\max}$, corresponds to the scenario where a variant accounts for its maximum possible contribution to the disease.\n$$CF_{\\max} \\times \\pi = K \\times g \\times a$$\n\nSolving for $CF_{\\max}$ gives:\n$$CF_{\\max} = \\frac{K \\times g \\times a}{\\pi}$$\n\nThe problem states that for a rare autosomal dominant disease, the population allele frequency ($AF$) is approximately one-half of the carrier frequency ($CF$). This is because in rare conditions, nearly all carriers are heterozygotes, carrying one copy of the variant allele. Thus, the frequency of the allele is half the frequency of the individuals who carry it.\n$$AF = \\frac{1}{2} CF$$\n\nApplying this relationship, we derive the formula for the maximum credible population allele frequency, $AF_{\\max}$.\n$$AF_{\\max} = \\frac{1}{2} CF_{\\max} = \\frac{Kga}{2\\pi}$$\n\nNow, we substitute the given numerical values into this derived formula:\n- $K = \\frac{1}{5000} = 0.0002$\n- $g = 0.2$\n- $a = 0.1$\n- $\\pi = 0.5$\n\n$$AF_{\\max} = \\frac{(0.0002) \\times (0.2) \\times (0.1)}{2 \\times (0.5)}$$\n$$AF_{\\max} = \\frac{0.000004}{1}$$\n$$AF_{\\max} = 0.000004$$\n\nThe problem defines the ratio $R$ as the observed allele frequency, $AF_{\\text{obs}}$, divided by the calculated maximum credible allele frequency, $AF_{\\max}$.\n$$R = \\frac{AF_{\\text{obs}}}{AF_{\\max}}$$\n\nWe are given $AF_{\\text{obs}} = 0.0006$. We can now compute the value of $R$.\n$$R = \\frac{0.0006}{0.000004}$$\n$$R = \\frac{6 \\times 10^{-4}}{4 \\times 10^{-6}} = \\frac{6}{4} \\times 10^{-4 - (-6)} = 1.5 \\times 10^{2}$$\n$$R = 150$$\n\nThe problem asks for the final answer to be rounded to three significant figures. The calculated value of $150$ can be written as $1.50 \\times 10^2$, which has three significant figures. Therefore, no further rounding is needed. The BS1 criterion is supported since $R = 150 \\ge 1$.", "answer": "$$\n\\boxed{150}\n$$", "id": "5021397"}, {"introduction": "While a high allele frequency can provide strong evidence for a benign classification, interpreting the *absence* of a variant requires much greater scrutiny. The PM2 criterion (absence from controls) is only meaningful if the genomic region is well-sequenced and reliably called across the control cohort. This exercise [@problem_id:5021401] delves into a challenging, real-world case involving the *PMS2* gene, forcing you to confront issues like low coverage, poor mapping quality, and pseudogene interference. It will teach you the critical skill of assessing data quality to decide when population data is informative and when it must be disregarded.", "problem": "A laboratory investigates a single-nucleotide deletion in the gene PMS2 in exon 12 (clinical suspicion: Lynch syndrome) located within a homopolymer of 8 adenines. The probandâ€™s variant is c.$2276$delA. Population data from the Genome Aggregation Database (gnomAD) are queried:\n\n- gnomAD v$2$ exomes report a site-level callable fraction at depth $\\ge 20\\times$ of $f_c^{20\\times} = 0.38$, with a median depth $D_{\\text{median}} = 12\\times$. The variant is absent. Per-ancestry allele numbers (AN) are: European $AN = 1800$, African $AN = 600$, Latino $AN = 450$, East Asian $AN = 700$.\n- gnomAD v$3$ genomes report $f_c^{20\\times} = 0.62$ and a median mapping quality $MQ_{\\text{median}} = 23$. The locus is flagged as being within a segmental duplication and homologous to the PMS2CL pseudogene. The variant is absent.\n\nYou must decide whether to apply the American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) criterion PM$2$ (absent from controls) to this variant. Using only core definitions from population genetics and sequencing technology (e.g., that absence in a population database informs rarity only when the site is well-called with adequate depth, mapping quality, and ancestry representation; that coverage depth $D$ and mapping quality $MQ$ define callability; and that homopolymer and segmental duplication contexts impair reliable detection), select the option that best justifies whether PM$2$ should be applied in this case and that proposes an explicit, quantitative guardrail for data sufficiency to decide PM$2$ applicability in similar cases.\n\nA. Apply PM$2$ because the variant is absent in gnomAD. A sufficient guardrail is simply absence in any gnomAD dataset without regard to $D$, $MQ$, or ancestry-specific $AN$.\n\nB. Do not apply PM$2$ here. A guardrail should require that either exomes or genomes achieve callable fraction $\\ge 90\\%$ at $D \\ge 30\\times$, per-ancestry $AN \\ge 20000$ for all major groups, and the locus is not in segmental duplication or homopolymer; otherwise treat population data as non-informative.\n\nC. Apply PM$2$ at a reduced strength (PM$2$_Supporting) because gnomAD shows absence despite some technical flags. A guardrail should consider coverage sufficient if $\\ge 50\\%$ of samples have $D \\ge 10\\times$ and $MQ \\ge 20$, regardless of segmental duplication or homopolymer context.\n\nD. Do not apply PM$2$ here and treat population data as non-informative because coverage, mapping, and context are inadequate. A guardrail should require all of the following: site-level callable fraction $\\ge 85\\%$ at $D \\ge 20\\times$ in both exomes and genomes, $MQ \\ge 30$, no segmental duplication or homopolymer length $\\ge 6$, and per major ancestry $AN \\ge 2000$; only then can absence be used for PM$2$.", "solution": "The user requests an evaluation of a clinical genetics problem regarding the application of the ACMG/AMP criterion PM$2$.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- **Variant:** c.$2276$delA in gene *PMS2*, exon 12.\n- **Clinical Context:** Suspicion of Lynch syndrome.\n- **Genomic Context:** Homopolymer of 8 adenines.\n- **gnomAD v$2$ Exomes Data:**\n    - Callable fraction at depth $\\ge 20\\times$: $f_c^{20\\times} = 0.38$.\n    - Median depth: $D_{\\text{median}} = 12\\times$.\n    - Variant is absent.\n    - Per-ancestry allele numbers (AN): European $AN = 1800$, African $AN = 600$, Latino $AN = 450$, East Asian $AN = 700$.\n- **gnomAD v$3$ Genomes Data:**\n    - Callable fraction at depth $\\ge 20\\times$: $f_c^{20\\times} = 0.62$.\n    - Median mapping quality: $MQ_{\\text{median}} = 23$.\n    - Locus is flagged as being within a segmental duplication.\n    - Locus is homologous to the *PMS2CL* pseudogene.\n    - Variant is absent.\n- **ACMG/AMP Criterion:** PM$2$ (absent from controls).\n- **Core Principles for Evaluation:**\n    1. Absence in population database informs rarity only when the site is well-called.\n    2. Well-called depends on adequate depth ($D$), mapping quality ($MQ$), and ancestry representation.\n    3. Homopolymer and segmental duplication contexts impair reliable detection.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem statement is scientifically grounded, well-posed, and objective. It provides a realistic clinical scenario involving the gene *PMS2*, which is notoriously difficult to sequence accurately due to high homology with the pseudogene *PMS2CL*. The data provided (callable fraction, depth, mapping quality, genomic context flags) are standard metrics used in genomics to assess data quality at a specific locus. The core principles provided for evaluation are fundamental to the correct interpretation of next-generation sequencing data. The problem is self-contained, with no internal contradictions or missing information required to make a reasoned judgment. The problem is valid.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A full solution will be derived.\n\n### Derivation of Solution\n\nThe decision to apply the ACMG/AMP criterion PM$2$ hinges on whether the absence of the variant in control databases (gnomAD) is informative. This requires a critical evaluation of the data quality at the variant's locus, c.$2276$ in the *PMS2* gene. We must analyze the provided data in the context of the core principles.\n\n1.  **Genomic Context:** The variant is located in two problematic contexts:\n    - A homopolymer of 8 adenines. Short-read sequencing technologies have high error rates for insertions and deletions (indels) within homopolymer tracts, especially those with length $\\ge 6$. The variant in question is a single-nucleotide deletion (c.$2276$delA), a type of indel. Therefore, its detection is inherently unreliable in this context.\n    - A segmental duplication and region of homology with the pseudogene *PMS2CL*. This is a critical issue. High sequence similarity between the gene and the pseudogene causes short sequencing reads to map ambiguously. This ambiguity leads to low mapping quality ($MQ$), which is a measure of confidence that a read has been placed correctly in the genome. The gnomAD v$3$ data confirms this, noting a median mapping quality $MQ_{\\text{median}} = 23$. This is a very low value; high-confidence variant calls typically require $MQ$ scores of at least 30, and often $>50$. Low $MQ$ reads are often filtered out, or down-weighted, meaning a true variant might be missed.\n\n2.  **Sequencing Coverage and Callability:**\n    - **gnomAD v2 (exomes):** A median depth of $D_{\\text{median}} = 12\\times$ is insufficient for confident heterozygous variant calling, particularly for an indel in a difficult region. Furthermore, the callable fraction at a minimal depth of $20\\times$ is only $f_c^{20\\times} = 0.38$. This means that at this anemic depth, we only have callable data for $38\\%$ of the exome-sequenced population. The remaining $62\\%$ cannot be confidently assessed.\n    - **gnomAD v3 (genomes):** While better, the callable fraction at $20\\times$ is still only $f_c^{20\\times} = 0.62$. This indicates that for $38\\%$ of the genome-sequenced population, the data is insufficient for reliable genotyping. For a criterion that relies on absence, having such a large fraction of the control population be uninformative is unacceptable.\n\n3.  **Allele Number ($AN$):** The provided allele numbers (e.g., European $AN = 1800$) represent the total number of alleles in that ancestry group, not the number of *callable* alleles. Given the low callable fractions ($0.38$ and $0.62$), the effective number of alleles for which a variant could have been confidently detected is much lower. For instance, using the v$2$ data, the effective European AN is at best approximately $1800 \\times 0.38 \\approx 684$. This sample size is too small to confidently assert rarity.\n\n**Conclusion on PM2 Application:**\nThe combination of a difficult genomic context (long homopolymer, segmental duplication), demonstrably low mapping quality ($MQ_{\\text{median}} = 23$), and poor coverage ($f_c^{20\\times}$ of $0.38$ and $0.62$) renders the population data from gnomAD non-informative at this locus. The absence of the variant c.$2276$delA does not mean the variant is rare; it means the databases were very likely unable to detect it had it been present. Therefore, applying PM$2$ is scientifically incorrect. The population data for this variant must be disregarded.\n\n### Option-by-Option Analysis\n\n**A. Apply PM$2$ because the variant is absent in gnomAD. A sufficient guardrail is simply absence in any gnomAD dataset without regard to $D$, $MQ$, or ancestry-specific $AN$.**\nThis option's recommendation to apply PM$2$ is incorrect, as derived above. The proposed guardrail is scientifically unsound, as it ignores all principles of data quality assessment in genomics. This approach would lead to frequent and significant errors in variant interpretation.\n**Verdict: Incorrect.**\n\n**B. Do not apply PM$2$ here. A guardrail should require that either exomes or genomes achieve callable fraction $\\ge 90\\%$ at $D \\ge 30\\times$, per-ancestry $AN \\ge 20000$ for all major groups, and the locus is not in segmental duplication or homopolymer; otherwise treat population data as non-informative.**\nThis option correctly recommends not to apply PM$2$. The proposed guardrail incorporates the correct principles (coverage, depth, ancestry, context). However, some thresholds are excessively stringent. A per-ancestry $AN \\ge 20000$ is far higher than most standard protocols and would severely limit the applicability of PM$2$. While safe, it is not a practical or standard guardrail.\n**Verdict: Incorrect.** The reasoning is sound, but the proposed guardrail is impractically strict, making it not the \"best\" justification among the choices.\n\n**C. Apply PM$2$ at a reduced strength (PM$2$_Supporting) because gnomAD shows absence despite some technical flags. A guardrail should consider coverage sufficient if $\\ge 50\\%$ of samples have $D \\ge 10\\times$ and $MQ \\ge 20$, regardless of segmental duplication or homopolymer context.**\nThis option's recommendation to apply PM$2$, even at a supporting level, is incorrect. The data is not weakly informative; it is non-informative. The proposed guardrail is dangerously lenient, using thresholds ($D \\ge 10\\times$, $MQ \\ge 20$) that are well below accepted standards for confident variant calling and explicitly ignoring critical confounders (segmental duplications, homopolymers).\n**Verdict: Incorrect.**\n\n**D. Do not apply PM$2$ here and treat population data as non-informative because coverage, mapping, and context are inadequate. A guardrail should require all of the following: site-level callable fraction $\\ge 85\\%$ at $D \\ge 20\\times$ in both exomes and genomes, $MQ \\ge 30$, no segmental duplication or homopolymer length $\\ge 6$, and per major ancestry $AN \\ge 2000$; only then can absence be used for PM$2$.**\nThis option correctly concludes that PM$2$ should not be applied and that the population data should be treated as non-informative due to inadequate quality. The proposed guardrail is excellent, comprehensive, and aligns with current best practices in clinical genomics.\n- $f_c \\ge 85\\%$ at $D \\ge 20\\times$: A strong and practical standard for coverage.\n- $MQ \\ge 30$: A reasonable minimum threshold for mapping quality, which correctly identifies the data for this *PMS2* variant ($MQ_{\\text{median}} = 23$) as inadequate.\n- no segmental duplication or homopolymer length $\\ge 6$: Specific and correct exclusion criteria for problematic genomic contexts. The given variant is in a homopolymer of length 8, so it would be correctly excluded.\n- per major ancestry $AN \\ge 2000$: A standard and statistically reasonable threshold for allele counts.\nThis option provides the correct action, the correct rationale, and the most scientifically sound and practical quantitative guardrail.\n**Verdict: Correct.**", "answer": "$$\\boxed{D}$$", "id": "5021401"}, {"introduction": "The ACMG/AMP framework provides general guidelines, but its true power is realized when tailored with gene-specific knowledge. The PM1 criterion, which relates to mutational hotspots and functional domains, is a prime candidate for such refinement. This advanced practice [@problem_id:5021410] moves beyond simple rule application to rule *design*, challenging you to build a computational model for the $\\text{MYH7}$ gene. You will translate biological data on protein domains and variant densities into a precise, hierarchical algorithm, gaining insight into how clinical genomics labs operationalize and automate variant classification.", "problem": "You are tasked with constructing a rule-based implementation of the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) framework criterion known as PM1 for the gene Beta-Myosin Heavy Chain ($\\text{MYH7}$), a well-studied cause of familial cardiomyopathy. The PM1 criterion considers whether a variant falls within a mutational hot spot or well-established functional domain without benign variation. Your rules must be derived from first principles using foundational definitions and well-tested facts, without relying on shortcut formulas.\n\nBegin from the following foundational base:\n- The central dogma of molecular biology establishes that variants that alter protein sequence (for example, missense) can affect function if they occur within critical protein domains. This is a qualitative statement, but it motivates the mapping from genomic variant to protein position.\n- The ACMG and AMP framework defines PM1 as applicable when a variant lies in a mutational hot spot or functional domain critical to protein function and where benign variation is absent or rare. This supplies the structural basis for rule design but not a computational implementation.\n- Population genetics facts: regions that tolerate benign variation will show relatively higher densities of benign missense observations, while constrained regions will show lower densities. This motivates a quantitative density threshold.\n- Experimentally validated domains provide evidence of functional criticality. These serve as domain boundaries for classification.\n\nYou must redesign PM1 for $\\text{MYH7}$ using the following experimentally validated domains, modeled as intervals on the protein sequence (amino acid positions, $p$, where $p$ is an integer):\n- Motor domain: start $p = 1$, end $p = 778$, marked as critical, with benign missense density $d = 0.6$ benign observations per $100$ residues, and hot spot density $h = 1.8$ pathogenic observations per $100$ residues.\n- Converter region: start $p = 706$, end $p = 790$, marked as critical, with $d = 0.3$ and $h = 4.2$.\n- Interacting-heads motif interface segment in the coiled-coil rod: start $p = 1780$, end $p = 1850$, marked as critical, with $d = 0.7$ and $h = 2.5$.\n- Coiled-coil rod domain: start $p = 840$, end $p = 1935$, marked as non-critical (supportive), with $d = 2.0$ and $h = 0.8$.\n\nAdditionally, incorporate site-level evidence of benign variation at specific residues, represented by a set of positions where a documented benign missense observation exists. Use the following set of positions for site-level benign evidence: $\\{100, 860, 1785\\}$.\n\nDefine PM1 strength levels as integers:\n- PM1 none: $0$,\n- PM1 supporting: $1$,\n- PM1 moderate: $2$,\n- PM1 strong: $3$.\n\nConstruct a decision rule for PM1 that maps a variant characterized by position $p$, variant type $t$, and a Boolean $b$ indicating whether a benign variant is documented at the exact residue ($b = \\text{True}$ if documented, otherwise $b = \\text{False}$), to a PM1 strength integer. Your decision rule must satisfy all of the following constraints and be derived from the above base:\n1. PM1 applies only to missense variants; for $t \\neq \\text{\"missense\"}$ set PM1 to $0$.\n2. If $b = \\text{True}$, set PM1 to $0$ regardless of domain context, to enforce the \"without benign variation\" clause.\n3. If multiple domains overlap a position $p$, select the domain with the smallest benign missense density $d$ to represent the strongest local evidence of constraint.\n4. Assign PM1 strong ($3$) if the selected domain is critical and simultaneously satisfies $d \\le 0.5$ and $h \\ge 2.0$.\n5. Assign PM1 moderate ($2$) if the selected domain is critical and satisfies at least one of $d \\le 1.5$ or $h \\ge 1.5$.\n6. Assign PM1 supporting ($1$) if the selected domain is validated (critical or supportive) and satisfies $d  2.5$.\n7. Otherwise assign PM1 none ($0$).\n\nAll densities ($d$) and hot spot measures ($h$) are to be treated as floats. No physical units are involved. Do not use percentages; express any proportional quantities as decimals.\n\nImplement this rule set as a complete, runnable program that processes the following test suite of variants, where each case is a tuple $(p, t, b)$:\n- Case $1$: $(725,\\ \\text{\"missense\"},\\ \\text{False})$\n- Case $2$: $(100,\\ \\text{\"missense\"},\\ \\text{True})$\n- Case $3$: $(900,\\ \\text{\"missense\"},\\ \\text{False})$\n- Case $4$: $(750,\\ \\text{\"nonsense\"},\\ \\text{False})$\n- Case $5$: $(820,\\ \\text{\"missense\"},\\ \\text{False})$\n- Case $6$: $(860,\\ \\text{\"missense\"},\\ \\text{True})$\n- Case $7$: $(1800,\\ \\text{\"missense\"},\\ \\text{False})$\n- Case $8$: $(790,\\ \\text{\"missense\"},\\ \\text{False})$\n- Case $9$: $(840,\\ \\text{\"missense\"},\\ \\text{False})$\n- Case $10$: $(500,\\ \\text{\"missense\"},\\ \\text{False})$\n- Case $11$: $(1785,\\ \\text{\"missense\"},\\ \\text{True})$\n\nYour program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets (for example, $\\text{\"[0,1,2]\"}$). The expected output list must contain the PM1 strength integers for the cases in the same order as listed.", "solution": "The problem statement is assessed to be valid. It is scientifically grounded in the principles of medical genetics, specifically the ACMG/AMP variant classification framework. It is well-posed, providing a complete and consistent set of definitions, data, and logical rules that permit the derivation of a unique solution for each test case. The problem is objective and formalizable.\n\nThe task is to construct and apply a set of decision rules to determine the strength of the PM1 evidence criterion for genetic variants in the $\\text{MYH7}$ gene. The provided parameters and rules will be formalized and then applied to each test case.\n\nFirst, we define the protein domains as data structures. Each domain has a name, a start and end position ($p$), a criticality status, a benign missense density ($d$), and a pathogenic hot spot density ($h$). All sequence positions are 1-based and inclusive.\n- **Motor domain**: $p \\in [1, 778]$, critical=True, $d=0.6$, $h=1.8$\n- **Converter region**: $p \\in [706, 790]$, critical=True, $d=0.3$, $h=4.2$\n- **Interacting-heads motif**: $p \\in [1780, 1850]$, critical=True, $d=0.7$, $h=2.5$\n- **Coiled-coil rod domain**: $p \\in [840, 1935]$, critical=False (supportive), $d=2.0$, $h=0.8$\n\nThe PM1 strength levels are encoded as integers: none ($0$), supporting ($1$), moderate ($2$), and strong ($3$).\n\nThe decision logic is a sequence of rules applied to an input variant specified by $(p, t, b)$, where $p$ is the amino acid position, $t$ is the variant type, and $b$ is a boolean indicating a known benign variant at that site. The rules must be applied in a specific hierarchical order.\n\n1.  If the variant type $t$ is not $\\text{\"missense\"}$, the PM1 score is $0$.\n2.  If a benign variant is documented at the site ($b = \\text{True}$), the PM1 score is $0$.\n3.  For a given position $p$, identify all overlapping domains. If multiple domains overlap, select the one with the minimum benign density $d$. If no domains overlap, no domain is selected.\n4.  If a domain is selected, apply the following hierarchical scoring rules:\n    a. (PM1 Strong, score $3$): The selected domain is critical AND its benign density $d \\le 0.5$ AND its hot spot density $h \\ge 2.0$.\n    b. (PM1 Moderate, score $2$): If not Strong, the selected domain is critical AND ($d \\le 1.5$ OR $h \\ge 1.5$).\n    c. (PM1 Supporting, score $1$): If not Strong or Moderate, the domain is validated (critical or supportive) AND $d  2.5$.\n    d. (PM1 None, score $0$): Otherwise. This also applies if no domain was selected in step $3$.\n\nWe now apply this full rule set to each test case.\n\n**Case 1: ($p=725$, $t=\\text{\"missense\"}$, $b=\\text{False}$)**\n- Rules $1$ and $2$: The variant is $\\text{\"missense\"}$ and $b$ is $\\text{False}$. We proceed.\n- Rule $3$: The position $p=725$ falls into two domains: Motor ($p \\in [1, 778]$, $d=0.6$) and Converter ($p \\in [706, 790]$, $d=0.3$). We select the Converter domain as it has the lower benign density ($0.3  0.6$).\n- Rule $4$: The selected domain (Converter) is critical, its $d=0.3 \\le 0.5$, and its $h=4.2 \\ge 2.0$. The conditions for PM1 Strong are met.\n- Result: $3$.\n\n**Case 2: ($p=100$, $t=\\text{\"missense\"}$, $b=\\text{True}$)**\n- Rule $2$: The boolean $b$ is $\\text{True}$.\n- Result: $0$.\n\n**Case 3: ($p=900$, $t=\\text{\"missense\"}$, $b=\\text{False}$)**\n- Rules $1$ and $2$: We proceed.\n- Rule $3$: The position $p=900$ falls only into the Coiled-coil rod domain ($p \\in [840, 1935]$, $d=2.0$, $h=0.8$, supportive). This domain is selected.\n- Rule $4$:\n    a. (Strong): This domain is not critical. Condition fails.\n    b. (Moderate): This domain is not critical. Condition fails.\n    c. (Supporting): The domain is validated (supportive). Its $d=2.0  2.5$. The condition for PM1 Supporting is met.\n- Result: $1$.\n\n**Case 4: ($p=750$, $t=\\text{\"nonsense\"}$, $b=\\text{False}$)**\n- Rule $1$: The variant type $t$ is $\\text{\"nonsense\"}$, not $\\text{\"missense\"}$.\n- Result: $0$.\n\n**Case 5: ($p=820$, $t=\\text{\"missense\"}$, $b=\\text{False}$)**\n- Rules $1$ and $2$: We proceed.\n- Rule $3$: The position $p=820$ does not fall into any of the defined domains. The last residue of the Converter domain is $790$ and the first residue of the Coiled-coil rod is $840$.\n- Rule $4$: No domain is selected, so we fall through to the 'otherwise' condition.\n- Result: $0$.\n\n**Case 6: ($p=860$, $t=\\text{\"missense\"}$, $b=\\text{True}$)**\n- Rule $2$: The boolean $b$ is $\\text{True}$.\n- Result: $0$.\n\n**Case 7: ($p=1800$, $t=\\text{\"missense\"}$, $b=\\text{False}$)**\n- Rules $1$ and $2$: We proceed.\n- Rule $3$: Position $p=1800$ falls into two domains: Interacting-heads ($p \\in [1780, 1850]$, $d=0.7$) and Coiled-coil rod ($p \\in [840, 1935]$, $d=2.0$). We select the Interacting-heads domain due to its lower benign density ($0.7  2.0$).\n- Rule $4$: The selected domain (Interacting-heads) has properties: critical=True, $d=0.7$, $h=2.5$.\n    a. (Strong): The domain is critical, but $d=0.7$ is not $\\le 0.5$. Condition fails.\n    b. (Moderate): The domain is critical. We check the OR condition: ($d \\le 1.5$ OR $h \\ge 1.5$). Since $d=0.7 \\le 1.5$ (and also $h=2.5 \\ge 1.5$), the condition is met.\n- Result: $2$.\n\n**Case 8: ($p=790$, $t=\\text{\"missense\"}$, $b=\\text{False}$)**\n- Rules $1$ and $2$: We proceed.\n- Rule $3$: Position $p=790$ falls only into the Converter region ($p \\in [706, 790]$). This domain is selected.\n- Rule $4$: The Converter domain is critical, $d=0.3 \\le 0.5$, and $h=4.2 \\ge 2.0$. The conditions for PM1 Strong are met.\n- Result: $3$.\n\n**Case 9: ($p=840$, $t=\\text{\"missense\"}$, $b=\\text{False}$)**\n- Rules $1$ and $2$: We proceed.\n- Rule $3$: Position $p=840$ falls only into the Coiled-coil rod domain ($p \\in [840, 1935]$).\n- Rule $4$:\n    a. (Strong): Not critical.\n    b. (Moderate): Not critical.\n    c. (Supporting): The domain is validated. Its $d=2.0  2.5$. Condition met.\n- Result: $1$.\n\n**Case 10: ($p=500$, $t=\\text{\"missense\"}$, $b=\\text{False}$)**\n- Rules $1$ and $2$: We proceed.\n- Rule $3$: Position $p=500$ falls only into the Motor domain ($p \\in [1, 778]$).\n- Rule $4$: The selected domain (Motor) has properties: critical=True, $d=0.6$, $h=1.8$.\n    a. (Strong): Domain is critical, but $d=0.6$ is not $\\le 0.5$. Condition fails.\n    b. (Moderate): Domain is critical. We check ($d \\le 1.5$ OR $h \\ge 1.5$). Since $d=0.6 \\le 1.5$ and $h=1.8 \\ge 1.5$, the condition is met.\n- Result: $2$.\n\n**Case 11: ($p=1785$, $t=\\text{\"missense\"}$, $b=\\text{True}$)**\n- Rule $2$: The boolean $b$ is $\\text{True}$.\n- Result: $0$.\n\nSummary of results:\n- Case 1: $3$\n- Case 2: $0$\n- Case 3: $1$\n- Case 4: $0$\n- Case 5: $0$\n- Case 6: $0$\n- Case 7: $2$\n- Case 8: $3$\n- Case 9: $1$\n- Case 10: $2$\n- Case 11: $0$\n\nThe final output is the list $[3,0,1,0,0,0,2,3,1,2,0]$. This derivation provides the foundation for the computational implementation.", "answer": "```python\nimport numpy as np\n\ndef solve():\n    \"\"\"\n    Implements a rule-based version of the ACMG/AMP PM1 criterion for MYH7 variants.\n    \"\"\"\n    \n    # Define the domain data from the problem statement.\n    # A domain is represented as a dictionary with its properties.\n    domains = [\n        {\n            \"name\": \"Motor domain\",\n            \"start\": 1, \"end\": 778, \"is_critical\": True,\n            \"d\": 0.6, \"h\": 1.8\n        },\n        {\n            \"name\": \"Converter region\",\n            \"start\": 706, \"end\": 790, \"is_critical\": True,\n            \"d\": 0.3, \"h\": 4.2\n        },\n        {\n            \"name\": \"Interacting-heads motif\",\n            \"start\": 1780, \"end\": 1850, \"is_critical\": True,\n            \"d\": 0.7, \"h\": 2.5\n        },\n        {\n            \"name\": \"Coiled-coil rod domain\",\n            \"start\": 840, \"end\": 1935, \"is_critical\": False,\n            \"d\": 2.0, \"h\": 0.8\n        }\n    ]\n\n    # Define the test suite of variants from the problem statement.\n    # Each case is a tuple (p, t, b) where:\n    # p: amino acid position (int)\n    # t: variant type (str)\n    # b: benign variant at site (bool)\n    test_cases = [\n        (725, \"missense\", False),\n        (100, \"missense\", True),\n        (900, \"missense\", False),\n        (750, \"nonsense\", False),\n        (820, \"missense\", False),\n        (860, \"missense\", True),\n        (1800, \"missense\", False),\n        (790, \"missense\", False),\n        (840, \"missense\", False),\n        (500, \"missense\", False),\n        (1785, \"missense\", True),\n    ]\n\n    def classify_pm1(p, t, b):\n        \"\"\"\n        Applies the decision rules to classify a variant and return its PM1 score.\n        \"\"\"\n        \n        # Rule 1: PM1 applies only to missense variants.\n        if t != \"missense\":\n            return 0\n        \n        # Rule 2: If a benign variant is documented, PM1 is none.\n        if b:\n            return 0\n\n        # Rule 3 (Part 1): Find all overlapping domains.\n        overlapping_domains = []\n        for domain in domains:\n            if domain[\"start\"] = p = domain[\"end\"]:\n                overlapping_domains.append(domain)\n        \n        # If no domain overlaps, return PM1 none (Rule 7).\n        if not overlapping_domains:\n            return 0\n            \n        # Rule 3 (Part 2): Select domain with smallest benign density 'd'.\n        selected_domain = min(overlapping_domains, key=lambda dom: dom['d'])\n\n        # Apply hierarchical scoring rules (Rules 4, 5, 6, 7).\n        is_critical = selected_domain[\"is_critical\"]\n        d = selected_domain[\"d\"]\n        h = selected_domain[\"h\"]\n\n        # Rule 4: PM1 Strong\n        if is_critical and d = 0.5 and h = 2.0:\n            return 3\n        \n        # Rule 5: PM1 Moderate\n        if is_critical and (d = 1.5 or h = 1.5):\n            return 2\n        \n        # Rule 6: PM1 Supporting\n        # A domain is 'validated' if it's critical or supportive.\n        # Since all our defined domains are one of these, we just check the 'd' constraint.\n        if d  2.5:\n            return 1\n            \n        # Rule 7: Otherwise, PM1 none.\n        return 0\n\n    results = []\n    for case in test_cases:\n        p_val, t_val, b_val = case\n        score = classify_pm1(p_val, t_val, b_val)\n        results.append(score)\n\n    # Final print statement in the exact required format.\n    print(f\"[{','.join(map(str, results))}]\")\n\nsolve()\n```", "id": "5021410"}]}